Delivery of genes capable of interfering with the intracellular replication cycle of HIV provides a novel therapeutic approach to treat or prevent HIV infection by gene therapy has been limited by difficulties in efficiently delivering the therapeutic gene into cells that are the primary targets of HIV infection. This limitation is being addressed by Dr. Strayer (Project #1) by the development of new SV40-based vectors capable of targeting hematopoietic stem/precursor cells, monocyte/macrophages and T cells. To evaluate the clinical usefulness of these new vector systems, it will be necessary to determine their capacity to transduce human hematopoietic precursor stem cells, by expressed in their mature progeny cells and protect the cells from in vivo HIV infection. By transplanting SCID mice with human fetal bone marrow and/or implanting them with human fetal thymus, we have developed an animal model that displays long-term human hematopoiesis in the mouse bone marrow and human thymopoiesis in the thymic implant that is associated with population of the murine periphery with human myeloid and T cells. We have demonstrated that these are a useful system for the in vivo assessment of hematopoietic stem/precursor cell-targeted gene therapy. The development of systemic HIV infection after intraimplant or i.p. inoculation by these mice makes them an attractive system for evaluating the effect of gene therapy on in vivo HIV infection. Therefore, we propose to use these systems to examine their in vivo capacity to transduce hematopoietic stem/precursor cells and thereby be expressed in the progeny cells or to directly target and mediate expression of the inserted gene in human T cells and monocytes. We will evaluates the function of the vectors by challenging the mice with HIV and thereby determining the capacity of these vectors to protect human cells from in vivo HIV infection. In addition, we will also evaluate the effect that transduction with these different vectors has on the subsequent hematopoiesis and thymopoiesis that occurs in these mice.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI048244-02
Application #
6484684
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2001-09-01
Project End
2002-08-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Type
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Louboutin, Jean-Pierre; Strayer, David S (2012) Blood-brain barrier abnormalities caused by HIV-1 gp120: mechanistic and therapeutic implications. ScientificWorldJournal 2012:482575
Louboutin, J-P; Chekmasova, A A; Reyes, B A S et al. (2011) Bone marrow-derived cells migrate to line the vessels of the CNS: opportunities for gene delivery to CNS vasculature. Neuroscience 195:215-23
Louboutin, Jean-Pierre; Reyes, Beverly A S; Agrawal, Lokesh et al. (2010) Blood-brain barrier abnormalities caused by exposure to HIV-1 gp120--protection by gene delivery of antioxidant enzymes. Neurobiol Dis 38:313-25
Strayer, David S; Mitchell, Christine; Maier, Dawn A et al. (2010) Production of SV40-derived vectors. Cold Spring Harb Protoc 2010:pdb.prot5436
Mueller, C; Strayer, M S; Sirninger, J et al. (2010) In vitro and in vivo functional characterization of gutless recombinant SV40-derived CFTR vectors. Gene Ther 17:227-37
Strayer, David S; Mitchell, Christine; Maier, Dawn A et al. (2010) Titering replication-defective rSV40 vectors. Cold Spring Harb Protoc 2010:pdb.prot5437
Louboutin, Jean-Pierre; Agrawal, Lokesh; Reyes, Beverly A S et al. (2010) HIV-1 gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to oxidative stress. J Neuropathol Exp Neurol 69:801-16
Agrawal, Lokesh; Maxwell, Christina R; Peters, Paul J et al. (2009) Complexity in human immunodeficiency virus type 1 (HIV-1) co-receptor usage: roles of CCR3 and CCR5 in HIV-1 infection of monocyte-derived macrophages and brain microglia. J Gen Virol 90:710-22
Louboutin, Jean-Pierre; Agrawal, Lokesh; Reyes, Beverly A S et al. (2009) A rat model of human immunodeficiency virus 1 encephalopathy using envelope glycoprotein gp120 expression delivered by SV40 vectors. J Neuropathol Exp Neurol 68:456-73
Louboutin, J-P; Agrawal, L; Reyes, B A S et al. (2007) Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors. Gene Ther 14:1650-61

Showing the most recent 10 out of 31 publications